Government Funding Accelerates Venture Interest In China
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
You may also be interested in...
Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
Innovation Sources For Medical Technology Begin Shift To Emerging Markets, But Large Capability Hurdles Remain - PwC Report
TOKYO - The U.S. has been the main source of medical technology innovation for many years, but the growing economies and technological capabilities of countries like China and India could soon shift the balance. The leading emerging markets are already making headway in becoming innovation leaders, although they will need to overcome large caveats that are stunting the development of innovative technologies